Medicine and Dentistry
Retinoblastoma
100%
Pediatrics
84%
Posttransplant Lymphoproliferative Disease
58%
Polycyclic Aromatic Hydrocarbon
53%
Diseases
51%
Neoplasm
45%
Oncology
40%
Transplantation
36%
Dietary Intake
35%
Cord Blood
32%
Health Care Cost
32%
Childhood Cancer
30%
Clinical Trial
29%
Chromosome Aberration
28%
Childhood Leukemia
26%
Burkitt's Lymphoma
26%
Genetic Screening
26%
Next Generation Sequencing
26%
Health Disparity
26%
Solid Organ Transplantation
24%
Malignant Neoplasm
23%
Prenatal Exposure
22%
Rituximab
20%
High Dose Chemotherapy
20%
Food Frequency Questionnaire
19%
Acute Lymphoblastic Leukemia
19%
Body Mass Index
18%
Nutrition
17%
Medulloblastoma
16%
Epstein Barr Virus
16%
Antioxidant
16%
Socioeconomic Status
16%
Event Free Survival
15%
Heart Transplantation
15%
Immunosuppressive Treatment
15%
Nutrient Intake
15%
Physical Activity
15%
Fluorescence in Situ Hybridization
15%
Case-Control Study
15%
Overall Survival
14%
Classical Hodgkin Lymphoma
13%
Cross Sectional Study
13%
Cancer Registry
13%
Diagnostic Delay
13%
Lymphoproliferative Disease
13%
Family Practice
13%
Cancer Mortality
13%
Ganglioneuroblastoma
13%
Cohort Analysis
13%
Gene Linkage
13%
Pharmacology, Toxicology and Pharmaceutical Science
Retinoblastoma
80%
Chemotherapy
62%
Posttransplant Lymphoproliferative Disease
53%
Diseases
53%
Polycyclic Aromatic Hydrocarbon
47%
Chromosome Aberration
41%
Rituximab
31%
Prenatal Exposure
23%
Cyclophosphamide
21%
Neoplasm
19%
High Dose Chemotherapy
19%
Case-Control Study
17%
Prednisone
15%
Obesity
15%
Human Papillomavirus
13%
Benzo(a)pyrene
13%
Androgen Receptor
13%
Folic Acid
13%
Stem Cell Factor Receptor
13%
Desmoplastic Small Round Cell Tumor
13%
1 Naphthol
13%
Environmental Exposure
13%
Antioxidant
13%
Androgen
13%
Classical Hodgkin Lymphoma
13%
Blood Lead Level
13%
Event Free Survival
12%
Naphthalene
11%
Sun Exposure
11%
Remission
8%
Papillomaviridae
7%
2 Naphthol
7%
Tacrolimus
7%
Etoposide
7%
Vitamin D
7%
Prospective Study
6%
Malignant Neoplasm
6%
Epstein-Barr Virus
6%
Base
5%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
5%
Placebo
5%
Lead Poisoning
5%
Biological Marker
5%
Prospective Cohort Study
5%
Nursing and Health Professions
Retinoblastoma
93%
Diseases
32%
Body Mass
26%
Posttransplant Lymphoproliferative Disease
26%
Drug Megadose
20%
Transplantation
15%
Carcinogen
15%
Institutional Review
14%
Immunosuppressive Treatment
13%
Lung Cancer
13%
Construct Validity
13%
Androgen
13%
Cigarette Filter
13%
Neoplasm
13%
Heart Graft
13%
Urban Population
13%
Diagnosis
13%
Genetic Screening
13%
Health Literacy
13%
Disease Burden
13%
Benzo[a]pyrene
13%
Stem Cell Factor Receptor
13%
Androgen Receptor
13%
Blood Lead Level
13%
Desmoplastic Small Round Cell Tumor
13%
Blood Level
13%
Folic Acid
13%
Burkitt's Lymphoma
13%
Glutathione
13%
Papilloma
13%
Caloric Intake
13%
Confidence Interval
12%
Organ Transplantation
10%
Body Fat
8%
Fat Content
8%
Event Free Survival
8%
Cyclophosphamide
8%
Trace Element
8%
Antioxidant
8%
Malignant Neoplasm
8%
Personalized Medicine
8%
Etoposide
7%
Tacrolimus
7%
Induction Chemotherapy
7%
Supplementation
6%
Cigarette Smoke
6%
Study Subject
6%
Systolic Blood Pressure
6%
Linear Regression Analysis
6%
Overall Survival
6%
